| Rank | Ticker | Country | Price | Revenue | Analyst Rating | Analysts | IPO Year |
|---|---|---|---|---|---|---|---|
#1 | TKO | United States | $182.27 | $4,735,151,000.00 | Strong Buy | 17 | 2023 |
#2 | KRG | United States | $26.12 | $844,365,000.00 | Buy | 10 | 2004 |
#3 | LIF | United States | $41.87 | $489,481,000.00 | Strong Buy | 11 | 2013 |
#4 | MCHP | United States | $71.41 | $5,349,500,000.00 | Buy | 22 | 2004 |
#5 | FTAI | United States | $189.29 | $2,507,409,000.00 | Strong Buy | 9 | 2014 |
#6 | AIR | United States | $124.48 | $0.00 | Strong Buy | 5 | 1994 |
#7 | SIG | Bermuda | $81.30 | $6,247,100,000.00 | Buy | 7 | 1997 |
#8 | RSI | United States | $25.75 | $1,134,428,000.00 | Strong Buy | 10 | 2020 |
#9 | TPR | United States | $122.14 | $5,880,000,000.00 | Buy | 17 | 2000 |
#10 | IVT | United States | $32.53 | $299,169,000.00 | Buy | 7 | 2005 |
#11 | EXTR | United States | $21.78 | $1,283,593,000.00 | Strong Buy | 5 | 1999 |
#12 | KEY | United States | $21.21 | $7,513,000,000.00 | Buy | 15 | 2005 |
#13 | SON | United States | $54.09 | $7,518,753,000.00 | Buy | 9 | 2014 |
#14 | SMG | United States | $59.10 | $3,016,500,000.00 | Buy | 6 | 2012 |
#15 | AZZ | United States | $135.75 | $1,061,817,000.00 | Buy | 5 | 1994 |
#16 | TREE | United States | $27.37 | $1,117,324,000.00 | Strong Buy | 4 | 2008 |
#17 | GMED | United States | $80.48 | $2,938,931,000.00 | Buy | 14 | 2012 |
#18 | ANIP | United States | $71.92 | $206,547,000.00 | Strong Buy | 5 | 1999 |
#19 | CSTM | France | $26.91 | $8,449,000,000.00 | Strong Buy | 4 | 2012 |
#20 | DCOM | United States | $39.45 | $19,907,000.00 | Buy | 5 | 1996 |
#21 | ASB | United States | $29.90 | $1,102,756,000.00 | Buy | 12 | 2014 |
#22 | PACS | United States | $42.14 | $5,288,932,000.00 | Strong Buy | 4 | 2024 |
#23 | GLW | United States | $145.61 | $15,629,000,000.00 | Buy | 12 | 2008 |
#24 | TTMI | United States | $115.33 | $2,906,345,000.00 | Strong Buy | 4 | 2000 |
#25 | BJRI | United States | $61.75 | $0.00 | Buy | 8 | 1996 |
#26 | EYE | United States | $16.69 | $1,987,488,000.00 | Strong Buy | 9 | 2017 |
#27 | DOCN | United States | $108.92 | $901,427,000.00 | Buy | 14 | 2021 |
#28 | LEVI | United States | $20.36 | $6,282,000,000.00 | Strong Buy | 12 | 2019 |
#29 | BHRB | United States | $70.63 | $0.00 | Buy | 5 | 2023 |
#30 | BXMT | United States | $13.81 | $0.00 | Buy | 5 | 1998 |
#31 | APEI | United States | $45.85 | $198,174,000.00 | Strong Buy | 7 | 2007 |
#32 | DRH | United States | $12.00 | $1,120,491,000.00 | Buy | 10 | 2004 |
#33 | SIRI | United States | $27.62 | $5,425,129,000.00 | Buy | 8 | 1996 |
#34 | CPT | United States | $105.96 | $12,967,000.00 | Buy | 17 | 1995 |
#35 | SPIR | United States | $12.02 | $110,451,000.00 | Strong Buy | 5 | 2020 |
#36 | PENG | United States | $47.59 | $1,368,794,000.00 | Strong Buy | 9 | 2017 |
#37 | BANC | United States | $18.16 | $1,818,792,000.00 | Strong Buy | 9 | 2002 |
#38 | LTH | United States | $41.83 | $2,995,255,000.00 | Strong Buy | 7 | 2021 |
#39 | DLR | United States | $183.27 | $6,112,692,000.00 | Buy | 22 | 2004 |
#40 | SWX | United States | $89.35 | $5,433,972,000.00 | Strong Buy | 5 | 2017 |
#41 | NVT | United Kingdom | $147.30 | $3,893,100,000.00 | Strong Buy | 11 | 2017 |
#42 | IPGP | United States | $75.20 | $1,003,777,000.00 | Strong Buy | 5 | 2000 |
#43 | SPHR | United States | $133.30 | $1,220,045,000.00 | Strong Buy | 12 | 2019 |
#44 | PFS | United States | $23.00 | $73,109,000.00 | Strong Buy | 4 | 2002 |
#45 | CPRI | United Kingdom | $12.79 | $3,474,000,000.00 | Buy | 13 | 2011 |
#46 | WRBY | United States | $24.19 | $871,905,000.00 | Buy | 11 | 2021 |
#47 | EPR | United States | $59.36 | $718,357,000.00 | Buy | 9 | 1997 |
#48 | NVST | United States | $26.64 | $2,566,500,000.00 | Buy | 13 | 2019 |
#49 | TRNO | United States | $66.45 | $476,383,000.00 | Buy | 12 | 2009 |
#50 | BLLN | United States | $92.32 | $305,112,000.00 | Buy | 7 | 2025 |
The FinQuota filters have identified what they believe to be the "Best Stocks Under $200 to Buy (September 2, 2026) | FinQuota" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.